- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant human acid ceramidase
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant human acid ceramidase
| EU orphan designation number: | EU/3/15/1536
|
| Active ingredient: | Recombinant human acid ceramidase |
| Indication: | Treatment of cystic fibrosis |
| Sponsor: | Plexcera Therapeutics EU Limited
77 Sir John Rogerson's Quay, Dublin 2, Ireland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 12/08/2015 | Orphan designation | EMA/OD/061/15 | (2015)5772 of 10/08/2015 |
CONTACT
EU links
Directorate General Health & Consumers